Actively Recruiting
Observational Study of Bone Marrow Imaging and Clinical Outcomes in Hematologic and Oncologic Conditions
Led by M.D. Anderson Cancer Center · Updated on 2026-09-18
1000
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an observational study involving patients with hematologic, oncologic, and other relevant conditions who undergo bone marrow imaging. The study aims to create a long-term group by combining bone marrow imaging data with clinical and treatment information to better understand bone marrow features and their changes over time. This includes exploring connections between imaging results, treatment effects, recovery, toxicities, and clinical outcomes. Participants will have clinical, imaging, laboratory, treatment, and outcome data collected from institutional records and research assessments when applicable. Imaging findings will be characterized across different patient groups, and changes will be monitored over time, especially following cancer therapy. The study also examines links between imaging and laboratory, pathology, or biomarker data when available. During the study, participants will provide informed consent and may undergo research MRI if eligible and safe. Data collection includes reviewing clinical records and research tests. The primary outcome is to observe bone marrow imaging characteristics over an average period of one year through study completion. This research is led by M.D. Anderson Cancer Center and continues until the end of 2038.
CONDITIONS
Brief Title
Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Research Team
O
Omran Saifi, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here